Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome [5] (multiple letters)

Sander Veldhuyzen Van Zanten, Eamonn M.M. Quigley, Liam O'Mahony, Fergus Shanahan

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome [5] (multiple letters)'. Together they form a unique fingerprint.